Revenue Information - Schedule of Revenue by Product Lines (Details) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Total product Revenues | $ 1,665,570 | $ 3,354,712 |
Product Revenue [Member] | ||
Total product Revenues | 1,665,570 | 3,304,712 |
License Fee | 50,000 | |
Total revenue | 1,665,570 | 3,354,712 |
MicroParticle Catalyzed Biosensor ("MPC") [Member] | ||
Total product Revenues | 123,941 | 381,228 |
Particle ImmunoFiltration Assay ("PIFA") [Member] | ||
Total product Revenues | 1,422,361 | 2,232,684 |
Rapid Enzymatic Assay ("REA") [Member] | ||
Total product Revenues | 68,750 | 133,848 |
Other [Member] | ||
Total product Revenues | $ 50,518 | $ 556,952 |
X | ||||||||||
- Definition License Fee. No definition available.
|
X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|